Edwards Lifesciences Corporation last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $1.7 billion (+10.5% year over year) and diluted EPS of $0.53. It usually reports 23–41 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 9, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Feb 10, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 23–41 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
1,716
+10.5%
|
308
+5.6%
|
0.53
+6.0%
|
|
Jul 23, 2026
23 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
1,741
+13.6%
|
242
-27.4%
|
0.42
-25.0%
|
|
Apr 23, 2026
23 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
1,649
+16.7%
|
381
+6.3%
|
0.66
+8.2%
|
|
Feb 10, 2026
41 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
1,570
+13.3%
|
91
-76.3%
|
0.16
-75.9%
|
|
Oct 30, 2025
30 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
1,553
+14.7%
|
291
-90.5%
|
0.50
-90.3%
|
|
Jul 24, 2025
24 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
1,532
+11.9%
|
333
-9.0%
|
0.56
-8.2%
|
|
Apr 23, 2025
23 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
1,413
+6.2%
|
358
+1.7%
|
0.61
+5.2%
|
|
Feb 11, 2025
42 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
1,386
+9.4%
|
386
+4.2%
|
0.65
+6.6%
|
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- EW (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1099800
- Former names
- CVG CONTROLLED INC (until Jan 21, 2000)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
- Cadre Holdings, Inc. CDRE
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.